Protagonist Therapeutics Inc (PTGX)

Total asset turnover

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Revenue (ttm)	US$ in thousands	315,090	60,137	123	123	982	26,704	35,221	45,507	46,913	27,380	24,330	27,139	31,091	28,549	25,678	12,604	6,408	4,321	3,955	10,051
Total assets	US$ in thousands	629,276	357,951	330,016	320,466	239,858	247,928	282,174	310,512	348,296	347,695	373,175	404,232	298,072	324,468	217,320	224,980	134,901	154,917	154,627	148,105
Total asset turnover		0.50	0.17	0.00	0.00	0.00	0.11	0.12	0.15	0.13	0.08	0.07	0.07	0.10	0.09	0.12	0.06	0.05	0.03	0.03	0.07

March 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $315,090K ÷ $629,276K
= 0.50

Protagonist Therapeutics Inc's total asset turnover has exhibited notable fluctuations over the periods analyzed. In the most recent quarter, the total asset turnover stood at 0.50, indicating that the company generated $0.50 in revenue for every dollar of assets. This represents a significant improvement from the previous quarter, where the turnover was 0.17. However, the turnover was negligible in the preceding quarters, showing signs of inefficiency in asset utilization.

The trend in total asset turnover suggests that Protagonist Therapeutics Inc has made progress in optimizing its asset utilization to generate more revenue relative to its asset base. It is essential for the company to sustain this improvement in asset turnover to enhance profitability and operational efficiency in the long term. Further analysis and monitoring of this ratio will be crucial to assess the company's effectiveness in maximizing its asset turnover and creating value for stakeholders.